Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

222.97
Delayed Data
As of 4:01pm ET
 -1.02 / -0.46%
Today’s Change
184.50
Today|||52-Week Range
256.80
+6.17%
Year-to-Date
Will Conatus Key Candidate Emricasan Drive Long-Term Growth?
6:24pm / Zacks.com - Paid Partner Content
Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices
Aug 16 / TheStreet.com - Paid Partner Content
My Observations and Takeaways
4:57pm / TheStreet.com - Paid Partner Content
Pressing AGN Again
Aug 16 / TheStreet.com - Paid Partner Content
Today's Trades
3:36pm / TheStreet.com - Paid Partner Content
Teva Is Cheap, Not Dead
Aug 16 / TheStreet.com - Paid Partner Content
Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain
Aug 17 / TheStreet.com - Paid Partner Content
Mid Afternoon Musings
Aug 15 / TheStreet.com - Paid Partner Content
PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round
Aug 16 / TheStreet.com - Paid Partner Content
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content
Valeant Pharmaceuticals: Cramer's Top Takeaways
Aug 16 / TheStreet.com - Paid Partner Content
Drug industry faces 'tidal wave' of litigation over opioid crisis
Aug 11 / FT.com - Paid Partner Content
The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)
Aug 16 / TheStreet.com - Paid Partner Content
Teva Plunges to 10-Year Low, Credit Rating in Jeopardy
Aug 09 / Zacks.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Valeant/Teva: lost summer
Aug 08 / FT.com - Paid Partner Content